Related Experiment Video
Updated: Aug 7, 2025

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates
Published on: February 27, 2016
Human sirtuin 2 inhibitors, their mechanisms and binding modes
André Berndt Penteado1, Haifa Hassanie1, Renan Augusto Gomes1
1School of Pharmaceutical Sciences, University of São Paulo, Av. Lineu Prestes, 580, Cidade Universitária, São Paulo, SP, 05508-000, Brazil.
Silent information regulators (sirtuins) are enzymes in epigenetic processes. This study details human sirtuin 2 (hSIRT2) inhibitors, aiding the development of new therapeutic agents targeting this enzyme.
Area of Science:
- Biochemistry
- Epigenetics
- Enzymology
Background:
- Sirtuins are a class of enzymes with lysine deacetylase activity.
- They regulate crucial cellular processes including gene expression, metabolism, and carcinogenesis.
- Sirtuins are recognized as significant therapeutic targets due to their roles in disease.
Purpose of the Study:
- To elucidate the inhibitory mechanisms of human sirtuin 2 (hSIRT2) inhibitors.
- To characterize the binding modes of hSIRT2 inhibitors within the enzyme's structure.
- To provide insights for the rational design of novel hSIRT2-targeting therapeutic agents.
Main Methods:
- Structural characterization of hSIRT2 inhibitor-enzyme complexes.
- Analysis of enzyme-inhibitor interactions at a molecular level.
Main Results:
- Detailed description of how various inhibitors interact with and inhibit hSIRT2.
- Identification of specific binding modes and structural features of effective inhibitors.
- Structural data that informs the mechanism of hSIRT2 inhibition.
Conclusions:
- Understanding hSIRT2 inhibitor mechanisms and binding modes is crucial for drug development.
- The structural insights gained can guide the rational design of more potent and selective hSIRT2 inhibitors.
- This research contributes to the development of novel therapeutic strategies targeting epigenetic dysregulation in diseases.
More Related Videos
10:20Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Related Concept Videos
Ligand Binding and Linkage
Enzyme Inhibition
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...